Metabolic Profiling in Maturity-Onset Diabetes of the Young (MODY) and Young Onset Type 2 Diabetes Fails to Detect Robust Urinary Biomarkers

It is important to identify patients with Maturity-onset diabetes of the young (MODY) as a molecular diagnosis determines both treatment and prognosis. Genetic testing is currently expensive and many patients are therefore not assessed and are misclassified as having either type 1 or type 2 diabetes...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Gloyn, Anna L., Faber, Johan H., Malmodin, Daniel, Thanabalasingham, Gaya, Lam, Francis, Ueland, Per Magne, McCarthy, Mark I., Owen, Katharine R., Baunsgaard, Dorrit
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2012
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3408469/
https://ncbi.nlm.nih.gov/pubmed/22859960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0040962
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים